Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
Anouchka SeesaghurPeter EggerJoshua WardenAli AbbasiBethany LevickMajid RiazPeter McMahonMatthew ThompsonSue CheesemanPublished in: BMJ open (2023)
In this study identifying BM diagnosis from both structured and unstructured data, a high proportion of patients did not receive a BTA. Unstructured data provide new insights on the real-world use of BTA.
Keyphrases
- electronic health record
- prostate cancer
- adverse drug
- clinical decision support
- end stage renal disease
- bone mineral density
- chronic kidney disease
- ejection fraction
- newly diagnosed
- healthcare
- soft tissue
- prognostic factors
- radical prostatectomy
- bone loss
- patient reported outcomes
- postmenopausal women
- peritoneal dialysis
- emergency department
- cross sectional
- acute care
- patient reported
- drug delivery